Galderma's Restylane Lyft with lidocaine is a hyaluronic acid-based filler approved for treating moderate to severe facial folds and wrinkles as well as volume loss in adult patients. Allergan's Juvederm Voluma also contains hyaluronic acid and lidocaine and is approved for filling lost volume in the cheeks. Facial plastic surgeon Andrew Jacono uses both but says the effects of Voluma might last longer.
The FDA approved Restylane Lyft hyaluronic acid-based injectable to augment cheeks and treat age-related midface contour deficiencies in patients at least 21 years old, manufacturer Galderma announced.
A new, hyaluronic acid-based filler restores volume to the face subtly and quickly, says plastic surgeon Garo Kassabian. Filling the cheek area lifts other parts of the face, he says. The procedure is quick and may result in some swelling or bruising, but Kassabian says side effects are usually minimal.
Different regulatory standards in Europe have catapulted hyaluronic acid-based fillers to the top of that market, with many more types available than in the U.S., experts say. High-cohesivity fillers are often used in body and buttocks remodeling, while low-cohesivity fillers are reserved for facial rejuvenation and filling fine lines. European plastic surgeons typically use a cannula for injections because it has a lower risk for pain, bruising, embolism and hematoma formation.
An FDA advisory panel recommended approval of Allergan's injectable Juvederm Voluma XC filler to treat age-related loss of midface volume. The product combines high- and low-molecular-weight hyaluronic acid and lidocaine and has a thick consistency intended for subcutaneous and supraperiosteal injection.